• myGriffith
    • Staff portal
    • Contact Us⌄
      • Future student enquiries 1800 677 728
      • Current student enquiries 1800 154 055
      • International enquiries +61 7 3735 6425
      • General enquiries 07 3735 7111
      • Online enquiries
      • Staff phonebook
    View Item 
    •   Home
    • Griffith Research Online
    • Journal articles
    • View Item
    • Home
    • Griffith Research Online
    • Journal articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

  • All of Griffith Research Online
    • Communities & Collections
    • Authors
    • By Issue Date
    • Titles
  • This Collection
    • Authors
    • By Issue Date
    • Titles
  • Statistics

  • Most Popular Items
  • Statistics by Country
  • Most Popular Authors
  • Support

  • Contact us
  • FAQs
  • Admin login

  • Login
  • Effect of atmospheric-pressure plasmas on drug resistant melanoma: The challenges of translating in vitro outcomes into animal models

    Author(s)
    Ishaq, M
    Rowe, A
    Bazaka, K
    Krockenberger, M
    Evans, MDM
    Ostrikov, KK
    Griffith University Author(s)
    Ostrikov, Ken
    Year published
    2016
    Metadata
    Show full item record
    Abstract
    Atmospheric-pressure plasmas (APs) have been identified as a promising cancer therapy that is able to preferentially kill neoplastic cells through apoptosis. In vitro studies suggest that AP-generated reactive oxygen species (ROS) are the principal triggers of apoptosis-related signaling cascades via oxidative stress and direct interference with DNA, proteins, and other cellular components. The results of this study corroborate an ROS-mediated mechanism of cancer cell death, with apoptosis in AP-treated Mel-007 melanoma cells inhibited by pretreatment of cells with the ROS scavenger N-acetylcysteine or the caspase inhibitor ...
    View more >
    Atmospheric-pressure plasmas (APs) have been identified as a promising cancer therapy that is able to preferentially kill neoplastic cells through apoptosis. In vitro studies suggest that AP-generated reactive oxygen species (ROS) are the principal triggers of apoptosis-related signaling cascades via oxidative stress and direct interference with DNA, proteins, and other cellular components. The results of this study corroborate an ROS-mediated mechanism of cancer cell death, with apoptosis in AP-treated Mel-007 melanoma cells inhibited by pretreatment of cells with the ROS scavenger N-acetylcysteine or the caspase inhibitor zVAD-fmk. In an effort to compare apoptosis mechanisms and evaluate the in vitro-in vivo correlation for AP-induced apoptosis, Mel-007 cells were injected subcutaneously into mice to form solid tumors and were treated with AP. Histological assessment of tumors from control and AP-treated animals showed no significant difference in tumor volume, mitotic rate, or percentage of necrosis or multinucleate cells. These results vary from those of other studies of AP treatment of xenograft tumors in murine models, in which a decrease in tumor size and tumor volume were observed. These findings focus our attention on challenges associated with translating the in vitro results to corresponding in vivo outcomes, and highlight concerns about the applicability of mechanisms established in vitro to an intrinsically dynamic in vivo environment.
    View less >
    Journal Title
    Plasma Medicine
    Volume
    6
    Issue
    1
    DOI
    https://doi.org/10.1615/PlasmaMed.2016015867
    Subject
    Atomic, molecular and optical physics
    Nuclear and plasma physics
    Biomedical engineering
    Medical biotechnology
    Publication URI
    http://hdl.handle.net/10072/409336
    Collection
    • Journal articles

    Footer

    Disclaimer

    • Privacy policy
    • Copyright matters
    • CRICOS Provider - 00233E

    Tagline

    • Gold Coast
    • Logan
    • Brisbane - Queensland, Australia
    First Peoples of Australia
    • Aboriginal
    • Torres Strait Islander